Cambridge Investment Research Advisors
CCIV.U

Cambridge Investment Research Advisors’s Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth CCIV.U Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CCIV.U Stock Details CCIV.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-99,868
Closed -$3.2M – 3264
2021
Q2 		$3.2M Buy
99,868
+34,483
+53% +$825K 0.02% 861
2021
Q1 		$1.68M Buy
+65,385
New +$1.91M 0.01% 1101

Cambridge Investment Research Advisors's CCIV.U Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth (CCIV.U) in Q3 2021, closing a stake of 99,868 shares — an estimated $3.2M sold.

Cambridge Investment Research Advisors first reported a position in CCIV.U in Q1 2021 and held it in 2 quarters. The position peaked at $3.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold CCIV.U as of Q3 2021.

  • Cambridge Investment Research Advisors reported no remaining Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth position as of Q3 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 99,868 Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth shares in Q3 2021, an estimated $3.2M.
  • Cambridge Investment Research Advisors first reported a position in Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth in Q1 2021 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth position peaked at $3.2M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.